We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAZ icon
4701
TransCode Therapeutics
RNAZ
$3.68M
0
RVPH
4702
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$8K ﹤0.01%
345
+323
+1,468% +$11.3K
SCHK icon
4703
Schwab 1000 Index ETF
SCHK
$5.98B
$8K ﹤0.01%
414
+400
+2,857% +$7.94K
SCM icon
4704
Stellus Capital Investment Corp
SCM
$254M
$8K ﹤0.01%
+708
New +$9.14K
SDOT icon
4705
Sadot Group
SDOT
$11.5M
$8K ﹤0.01%
10
+3
+43% +$2.5K
SLS icon
4706
SELLAS Life Sciences
SLS
$2.5B
$8K ﹤0.01%
3,755
+3,291
+709% +$9.65K
SNGX icon
4707
Soligenix
SNGX
$8.29M
$8K ﹤0.01%
56
+20
+56% +$2.77K
SKYA
4708
SkyAI Inc
SKYA
$43M
$8K ﹤0.01%
+1
New +$7.97K
SWAG icon
4709
Stran & Co
SWAG
$36.3M
$8K ﹤0.01%
4,877
-1,324
-21% -$2.4K
SWKH
4710
DELISTED
SWK Holdings
SWKH
$8K ﹤0.01%
549
-212
-28% -$3.15K
SYRE icon
4711
Spyre Therapeutics
SYRE
$8.98B
$8K ﹤0.01%
628
-255
-29% -$8.94K
TYGO icon
4712
Tigo Energy
TYGO
$96.7M
$8K ﹤0.01%
757
+99
+15% +$985
UGL icon
4713
ProShares Ultra Gold
UGL
$792M
$8K ﹤0.01%
600
+64
+12% +$980
FLZH
4714
Flash Sports & Media Holdings
FLZH
$74.9M
$8K ﹤0.01%
64
-44
-41% -$7.38K
VEU icon
4715
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
$8K ﹤0.01%
+158
New +$8.46K
VRNA
4716
DELISTED
Verona Pharma
VRNA
$8K ﹤0.01%
2,126
+1,095
+106% +$4.68K
WRN
4717
Western Copper and Gold
WRN
$541M
$8K ﹤0.01%
5,844
+5,554
+1,915% +$10.1K
WVE icon
4718
Wave Life Sciences
WVE
$1.02B
$8K ﹤0.01%
2,587
-2,225
-46% -$4.28K
TPC
4719
Tutor Perini Cor
TPC
$4.98B
$8K ﹤0.01%
958
+480
+100% +$4.63K
TBNK
4720
DELISTED
Territorial Bancorp Inc.
TBNK
$8K ﹤0.01%
388
+100
+35% +$2.22K
PIK
4721
DELISTED
Kidpik Corp. Common Stock
PIK
$8K ﹤0.01%
1,182
+771
+188% +$8.27K
GLLIU
4722
DELISTED
Globalink Investment Inc. Unit
GLLIU
$8K ﹤0.01%
800
DPCSU
4723
DELISTED
DP Cap Acquisition Corp I Unit
DPCSU
$8K ﹤0.01%
777
FRLA
4724
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$8K ﹤0.01%
822
+4
+0.5% +$40
FUSN
4725
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$8K ﹤0.01%
+3,259
New +$15K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.